Drug Shortage Report for MYOZYME
| Report ID | 176406 |
| Drug Identification Number | 02284863 |
| Brand name | MYOZYME |
| Common or Proper name | MYOZYME |
| Company Name | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALGLUCOSIDASE ALFA |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 |
| ATC code | A16AB |
| ATC description | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-12-02 |
| Actual start date | |
| Estimated end date | 2022-12-15 |
| Actual end date | 2022-12-06 |
| Shortage status | Resolved |
| Updated date | 2022-12-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer service contact info: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-12-07 | English | Compare |
| v5 | 2022-12-06 | French | Compare |
| v4 | 2022-12-06 | English | Compare |
| v3 | 2022-12-03 | English | Compare |
| v2 | 2022-11-30 | French | Compare |
| v1 | 2022-11-30 | English | Compare |
Showing 1 to 6 of 6